Annual EBITDA
-$30.74 M
+$315.00 K+1.01%
31 December 2023
Summary:
Sagimet Biosciences - Seri annual earnings before interest, taxes, depreciation & amortization is currently -$30.74 million, with the most recent change of +$315.00 thousand (+1.01%) on 31 December 2023. During the last 3 years, it has fallen by -$19.37 million (-170.36%). SGMT annual EBITDA is now -170.36% below its all-time high of -$11.37 million, reached on 01 December 2020.SGMT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$16.90 M
-$6.31 M-59.62%
30 September 2024
Summary:
Sagimet Biosciences - Seri quarterly earnings before interest, taxes, depreciation & amortization is currently -$16.90 million, with the most recent change of -$6.31 million (-59.62%) on 30 September 2024. Over the past year, it has dropped by -$9.45 million (-126.81%). SGMT quarterly EBITDA is now -321.81% below its all-time high of -$4.01 million, reached on 01 March 2020.SGMT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$45.73 M
-$9.45 M-26.05%
30 September 2024
Summary:
Sagimet Biosciences - Seri TTM earnings before interest, taxes, depreciation & amortization is currently -$45.73 million, with the most recent change of -$9.45 million (-26.05%) on 30 September 2024. Over the past year, it has dropped by -$17.06 million (-59.53%). SGMT TTM EBITDA is now -1041.13% below its all-time high of -$4.01 million, reached on 01 March 2020.SGMT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | -126.8% | -59.5% |
| 3 y3 years | -170.4% | -251.9% | -852.0% |
| 5 y5 years | - | - | - |
SGMT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -170.4% | +1.0% | -251.9% | at low | -852.0% | at low |
| 5 y | 5 years | -170.4% | +1.0% | -321.8% | at low | -1041.1% | at low |
| alltime | all time | -170.4% | +1.0% | -321.8% | at low | -1041.1% | at low |
Sagimet Biosciences - Seri EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.90 M(+59.6%) | -$45.73 M(+26.1%) |
| June 2024 | - | -$10.59 M(+20.8%) | -$36.27 M(+10.8%) |
| Mar 2024 | - | -$8.77 M(-7.4%) | -$32.74 M(+6.5%) |
| Dec 2023 | -$30.74 M(-1.0%) | -$9.47 M(+27.0%) | -$30.74 M(+7.3%) |
| Sept 2023 | - | -$7.45 M(+5.6%) | -$28.66 M(-0.8%) |
| June 2023 | - | -$7.06 M(+4.3%) | -$28.90 M(-0.6%) |
| Mar 2023 | - | -$6.76 M(-8.4%) | -$29.08 M(-6.4%) |
| Dec 2022 | -$31.05 M | -$7.39 M(-3.9%) | -$31.05 M(+31.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$7.69 M(+6.2%) | -$23.67 M(+48.1%) |
| June 2022 | - | -$7.24 M(-17.2%) | -$15.98 M(+82.8%) |
| Mar 2022 | - | -$8.74 M(+82.0%) | -$8.74 M(+82.0%) |
| Dec 2021 | -$23.72 M(+108.6%) | - | - |
| Mar 2021 | - | -$4.80 M(+19.9%) | -$4.80 M(+19.9%) |
| Dec 2020 | -$11.37 M(-19.9%) | - | - |
| Mar 2020 | - | -$4.01 M | -$4.01 M |
| Dec 2019 | -$14.20 M | - | - |
FAQ
- What is Sagimet Biosciences - Seri annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Sagimet Biosciences - Seri?
- What is Sagimet Biosciences - Seri annual EBITDA year-on-year change?
- What is Sagimet Biosciences - Seri quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Sagimet Biosciences - Seri?
- What is Sagimet Biosciences - Seri quarterly EBITDA year-on-year change?
- What is Sagimet Biosciences - Seri TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Sagimet Biosciences - Seri?
- What is Sagimet Biosciences - Seri TTM EBITDA year-on-year change?
What is Sagimet Biosciences - Seri annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SGMT is -$30.74 M
What is the all time high annual EBITDA for Sagimet Biosciences - Seri?
Sagimet Biosciences - Seri all-time high annual earnings before interest, taxes, depreciation & amortization is -$11.37 M
What is Sagimet Biosciences - Seri annual EBITDA year-on-year change?
Over the past year, SGMT annual earnings before interest, taxes, depreciation & amortization has changed by +$315.00 K (+1.01%)
What is Sagimet Biosciences - Seri quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SGMT is -$16.90 M
What is the all time high quarterly EBITDA for Sagimet Biosciences - Seri?
Sagimet Biosciences - Seri all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$4.01 M
What is Sagimet Biosciences - Seri quarterly EBITDA year-on-year change?
Over the past year, SGMT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.45 M (-126.81%)
What is Sagimet Biosciences - Seri TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SGMT is -$45.73 M
What is the all time high TTM EBITDA for Sagimet Biosciences - Seri?
Sagimet Biosciences - Seri all-time high TTM earnings before interest, taxes, depreciation & amortization is -$4.01 M
What is Sagimet Biosciences - Seri TTM EBITDA year-on-year change?
Over the past year, SGMT TTM earnings before interest, taxes, depreciation & amortization has changed by -$17.06 M (-59.53%)